Shan Dong Kexing Bioproducts Co (SHSE:688136) Long-Term Capital Lease Obligation : ¥22 Mil (As of Mar. 2024)

View and export this data going back to 2020. Start your Free Trial

What is Shan Dong Kexing Bioproducts Co Long-Term Capital Lease Obligation?

Shan Dong Kexing Bioproducts Co's Long-Term Capital Lease Obligation for the quarter that ended in Mar. 2024 was ¥22 Mil.

Shan Dong Kexing Bioproducts Co's quarterly Long-Term Capital Lease Obligation declined from Sep. 2023 (¥20 Mil) to Dec. 2023 (¥18 Mil) but then increased from Dec. 2023 (¥18 Mil) to Mar. 2024 (¥22 Mil).

Shan Dong Kexing Bioproducts Co's annual Long-Term Capital Lease Obligation declined from Dec. 2021 (¥43 Mil) to Dec. 2022 (¥25 Mil) and declined from Dec. 2022 (¥25 Mil) to Dec. 2023 (¥18 Mil).

Shan Dong Kexing Bioproducts Co Long-Term Capital Lease Obligation Historical Data

The historical data trend for Shan Dong Kexing Bioproducts Co's Long-Term Capital Lease Obligation can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Shan Dong Kexing Bioproducts Co Long-Term Capital Lease Obligation Chart

Shan Dong Kexing Bioproducts Co Annual Data

Trend

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Long-Term Capital Lease Obligation

Get a 7-Day Free Trial

28.42

43.25

24.96

17.79

Shan Dong Kexing Bioproducts Co Quarterly Data
	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Long-Term Capital Lease Obligation	Get a 7-Day Free Trial															21.20	21.05	20.27	17.79	21.55

Shan Dong Kexing Bioproducts Co (SHSE:688136) Long-Term Capital Lease Obligation Explanation

Long-Term Capital Lease Obligation are the amount due for long-term asset lease agreements that are nearly equivalent to asset purchases. Capital lease obligations are installment payments that constitute a payment of principal plus interest for the capital lease. The Short-Term Capital Lease Obligation is the portion of a Long-Term Capital Lease Obligation that is due over the next year.

Under US Generally Accepted Accounting Principles (GAAP), a capital lease is essentially equivalent to a purchase by the lessee if it meets the following criteria:

1. Ownership of the asset is transferred to the lessee at the end of the lease term;
2. The lease contains a bargain purchase option to buy the equipment at less than fair market value;
3. The lease term equals or exceeds 75% of the asset's estimated useful life;
4. The present value of the lease payments equals or exceeds 90% of the total original cost of the equipment.

Shan Dong Kexing Bioproducts Co Long-Term Capital Lease Obligation Related Terms

Thank you for viewing the detailed overview of Shan Dong Kexing Bioproducts Co's Long-Term Capital Lease Obligation provided by GuruFocus.com. Please click on the following links to see related term pages.

Shan Dong Kexing Bioproducts Co (SHSE:688136) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Shan Dong Kexing Bioproducts Co Ltd (SHSE:688136) » Definitions » Long-Term Capital Lease Obligation

Comparable Companies

Traded in Other Exchanges

N/A

Address

No. 2666, Chuangye Road, Mingshui Development Zone, Zhangqiu District, Shandong Province, Jinan, CHN, 250200

Website

http://www.kexing.com

Shan Dong Kexing Bioproducts Co Ltd formerly Kexing Biopharmaceutical Co Ltd is an innovative biopharmaceutical company. It is engaged in the production and sales of recombinant protein drugs and probiotics. The company use the drugs in the fields of antiviral, hematology, tumor and immunity, and degenerative diseases.

Executives

Wang Xiao Qin	Directors, senior managers
Cui Ning	Directors, senior managers
Ma Hong Jie	senior management
Shao Ke	senior management
Deng Xue Qin	Director
Zhao Yan Qing	Directors, senior managers

Shan Dong Kexing Bioproducts Co (SHSE:688136) Headlines

No Headlines